Amgen goes pivotal with subcutaneous Blincyto
A new first-line maintenance phase 3 joins a relapsed pivotal phase 2 study.
Sutro goes back to work
The restructured biotech’s new lead project enters phase 1.
Pfizer speeds ahead with bispecific development
The company will imminently start its third pivotal trial of PF-08634404.
Genmab pushes rina-S into its third phase 3
The Rainfol-04 trial in platinum-sensitive ovarian cancer will start next year.
BeOne joins the Kat6 pack
BG-75202 features among several projects starting first-in-human trials.
Pfizer moves into the VEGF bispecific fast lane
There will soon be three PD-(L)1 x VEGF projects in pivotal lung and colorectal cancer trials.
Nuvation reroutes its glioma plan
The company will no longer initiate a head-to-head trial of safusidenib against Voranigo.
Gastrointestinal is next for pumitamig
Bristol will advance the newest pivotal trials, in first-line colorectal and gastric cancers.
